Skip to content
ZYMOPTIQ logo β€” Easier, faster, cheaper enzyme activity assay to understand...

ZYMOPTIQ

Easier, faster, cheaper enzyme activity assay to understand and control your enzymes. πŸ‘πŸ§¬πŸ§«πŸ”¬

Founded 2019 France France 19 employees Non Equity Assistance Biotechnology

General Information

Company Name ZYMOPTIQ
Founded Year 2019
Location France France
Employees 19
Industries Biotechnology
Funding Stage Non Equity Assistance
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with ZYMOPTIQ. To contact ZYMOPTIQ, visit zymoptiq.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ZYMOPTIQ compare?

A PDF of ZYMOPTIQ and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ZYMOPTIQ soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ZYMOPTIQ

ZYMOPTIQ, founded in 2019, is a France-based biotechnology startup poised to revolutionize enzyme analysis with its disruptive tools for enzyme activity assays. The company boasts a compelling slogan: "Easier, faster, cheaper enzyme activity assay to understand and control your enzymes. πŸ‘πŸ§¬πŸ§«πŸ”¬". Their innovative products allow for rapid, straightforward, and cost-effective enzyme characterization, making them highly attractive to industries reliant on enzyme applications.

The enzymatic solutions offered by ZYMOPTIQ are user-friendly, ready-to-use, and designed to streamline enzymatic tests efficiently. Despite being a relatively young player in the market, the firm has drawn attention thanks to its transformative potential in the biotechnology sector.

The company's most recent financing event was a Non Equity Assistance investment on 22 January 2018 from Eurasante. As the firm continues to grow, it presents a promising opportunity for investors looking to enter the biotechnology space with a focus on innovation and efficiency.

Business keywords: enzyme activity assay, analytical tool, enzyme characterization, optical reading, enzyme measurement, user-friendly products, enzymatic products, disruptive technology, enzyme control, fast testing, simple testing, affordable testing, measurement services, online inquiry

Services & Products

Enzyme Analysis
Metrology Equipment
Customized Enzyme Solutions
Analytical Testing

Target Customers

Food Industry Dairy Producers Biofuel Companies Industrial Cleaners Cosmetics Manufacturers Enzyme Producers Animal Feed Industry

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Eurasante
22 Jan 2018

ZYMOPTIQ Alternatives & Competitors

View All Alternatives
ZYMOPTIQ vs
Xylogenics, Inc.
Xylogenics, Inc. United States

Redefining Fermentation

Seed
9 employees
Biotechnology, Clean Energy
ZYMOPTIQ vs
Entobel
Entobel Singapore

Entobel is an agritech/biotech company focusing on the production and processing of insects.

Series B
71 employees
Agriculture, Biotechnology
ZYMOPTIQ vs

SomaTech's enabling deep tech offers a sustainable solution for by product valorization

Pre-Seed
4 employees
Biotechnology

FAQ About ZYMOPTIQ

Easier, faster, cheaper enzyme activity assay to understand and control your enzymes. πŸ‘πŸ§¬πŸ§«πŸ”¬
ZYMOPTIQ was founded in 2019.
ZYMOPTIQ is headquartered in France.
ZYMOPTIQ operates in Biotechnology. Its work centres on enzyme activity assay, analytical tool, enzyme characterization and optical reading. Its customers include Food Industry, Dairy Producers and Biofuel Companies.
ZYMOPTIQ has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
ZYMOPTIQ has approximately 19 employees.
ZYMOPTIQ has completed 1 funding round. The latest funding stage is Non Equity Assistance.
ZYMOPTIQ offers: Enzyme Analysis, Metrology Equipment, Customized Enzyme Solutions, Analytical Testing.
Top alternatives and competitors to ZYMOPTIQ include Xylogenics, Inc., Entobel, SomaTech Ltd, LIVZYM BIOTECHNOLOGIES, PhageLab. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZYMOPTIQ and Xylogenics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ZYMOPTIQ, https://bouncewatch.com/company/zymoptiq, updated 23 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout